Press Release – New Facility

Pelago Bioscience AB expands to new facility

After several years of continued growth in our current facilities Pelago Bioscience now really expands. The new building is located at Campus Solna, a rapidly developing Life Science cluster located in central Stockholm. This new state-of-the-art facility is three times our current area and enables us to keep up with the demand for our services, providing biologically relevant target engagement data to drug discovery and development clients worldwide.

The move to the new facility is expected to occur in late Q4, 2021, preparing the company for further scaling up our service offerings in 2022. By being an active partner in the Life Science community the company will further strengthen and develop its position as a leader in cutting edge drug discovery.

“We have experienced a very strong growth since incorporating the company, and we take great pride in knowing our customers are bringing new medicines to market more quickly thanks to our help. We are very excited about this move, investing in the future of Pelago, to increase our customers accessibility to our expertise in drug discovery, focusing on the patented CETSA® technology” – Michael Dabrowski, CEO


Full Press Release


(Photo by Akademiska Hus)

Are you sure?

Is you target compound really theraputic?

Speak to our experts

Learn how CETSA® can enable your project by talking to one of our Drug Discovery experts.